Publications

Showing 121 to 130 of 540 Publications
Title Authors
CCNA Researchers* / CCNA Trainees**
Year Journal
In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240 Pascoal, T. A., Shin, M., Kang, M. S., Chamoun, M., Chartrand, D., Mathotaarachchi, S., Bennacef, I., Therriault, J., Ng, K. P., Hopewell, R., Bouhachi, R., Hsiao, H. H., Benedet, A. L., Soucy, J. P., Massarweh, G., Gauthier, S., & Rosa-Neto, P. 2018 Alzheimer's Research and Therapy
The Canadian Dementia Imaging Protocol: Harmonizing national cohorts Duchesne, S., Chouinard, I., Potvin, O., Fonov, V.S., Khademi, A., Bartha, R., Bellec, P., Collins, D.L., Descoteaux, M., Hoge, R., McCreary, C.R., Ramirez, J., Scott, C.J.M., Smith, E.E., Strother, S.C., Black, S.E. 2018 Journal of Magnetic Resonance Imaging
APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts Weishaupt, N., Liu, Q., Shin, S., Singh, R., Agca, Y., Agca, C., Hachinski, V., & Whitehead, S.N. 2018 Journal of Neuroinflammation
The GBA p Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies Ruskey, J.A., Zhou, S., Santiago, R., Franche, L.A., Alam, A., Ronciere, L., Spiegelman, D., Fon, E.A., Trempe, J.F., Kalia, L.V., Postuma, R.B., Dupre, N., Rivard, G.E., Assouline, S., Amato, D., & Gan-Or, Z. 2018 Clinical Genetics
A network of genetic effects on non-demented cognitive aging: Alzheimer’s genetic risk (CLU + CR1+PICALM) intensifies cognitive Aging genetic risk (COMT + BDNF) selectively for APOE4 carriers Sapkota, S., & Dixon, R. A. 2018 Journal of Alzheimer's Disease
Alzheimer’s biomarkers from multiple modalities selectively discriminate clinical status: Relative importance of salivary metabolomics panels, genetic, lifestyle, cognitive, functional health and demographic risk markers Sapkota, S., Huan, T., Tran T., Zheng, J., Camicioli, R., Li, L. & Dixon, R.A. 2018 Frontiers in Aging Neuroscience
Emotion and motivation in cognitive assistive technologies for dementia Robillard, J.M. & Hoey, J. 2018 Computer
Metabolomics analyses of saliva detect novel biomarkers of Alzheimer’s disease Huan, T., Tran, T., Zheng, J., Sapkota, S., Camicioli, R., Dixon, R.A., & Li, L. 2018 Journal of Alzheimer's Disease
TOX3 variants are involved in restless legs syndrome and Parkinson’s Disease with opposite effects Mohtashami, S., He, Q., Ruskey, J.A., Zhou, S., Dion, P.A., Allen, R.P., Earley, C.J., Fon, E.A., Xiong, L., Dupre, N., Dauvillers, Y., Rouleau, G.A., & Gan-Or, Z. 2018 Journal of Molecular Neuroscience
Alzheimer’s Disease Neuroimaging Initiative. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease. Pascoal T.A.**, Mathotaarachchi S.**, Shin M.**, Park A.Y., Mohades S., Benedet A.L.**, Kang M.S., Massarweh G., Soucy J.P.**, Gauthier S.**, Rosa-Neto P.** 2018 European Journal of Nuclear Medicine and Molecular Imaging
Showing 121 to 130 of 540 Publications
Go back to top